NKTR
Nektar Therapeutics
3월 13일 4:00 PM ET (한국 3/14 05:00)
$73.25
+2.89 ▲ +4.11%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$73.38
+0.13 ▲ +0.18%
| Index | - | P/E | - | EPS (ttm) | -10.22 | Insider Own | 3.95% | Shs Outstand | 0.03B | Perf Week | 3.61% |
| Market Cap | 2.05B | Forward P/E | - | EPS next Y | -11.61% | Insider Trans | -0.76% | Shs Float | 0.03B | Perf Month | 10.4% |
| Enterprise Value | 1.95B | PEG | - | EPS next Q | -1.97 | Inst Own | 71.14% | Short Float | 12.44% | Perf Quarter | 26.86% |
| Income | -0.16B | P/S | 37.11 | EPS this Y | -7.34% | Inst Trans | 11.08% | Short Ratio | 2.81 | Perf Half Y | 55.19% |
| Sales | 0.06B | P/B | 16.62 | EPS next 5Y | -11.58% | ROA | -56.17% | Short Interest | 3.34M | Perf YTD | 73.25% |
| Book/sh | 4.41 | P/C | 8.34 | EPS past 3/5Y | 30.93% 23.59% | ROE | -217.94% | 52W High | -3.2% ($75.67) | Perf Year | 8883.32% |
| Cash/sh | 8.78 | P/FCF | - | Sales past 3/5Y | -15.66% -18.43% | ROIC | -75.18% | 52W Low | 16856.02% ($0.43) | Perf 3Y | 306.94% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -17.07% | Gross Margin | 98.14% | Volatility(W/M) | 7.23% 7.02% | Perf 5Y | -78.6% |
| Dividend TTM | - | EV/Sales | 35.36 | Sales Y/Y TTM | -43.89% | Oper. Margin | -236.77% | ATR (14) | 4.68 | Perf 10Y | -62.06% |
| Dividend Ex-Date | - | Quick Ratio | 4.97 | EPS Q/Q | -448.62% | Profit Margin | -297.07% | RSI (14) | 63.78 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.97 | Sales Q/Q | -25.25% | SMA20 | 3.02% ($71.1) | Beta | -0.85 | Target Price | $138.67 |
| Payout | - | Debt/Eq | 1.66 | Earnings | 3000000 | SMA50 | 38.11% ($53.04) | Rel Volume | 1.15 | Prev Close | $70.36 |
| Employees | 63 | LT Debt/Eq | 1.43 | EPS/Sales Surpr. | 28.05% 114.01% | SMA200 | 69.89% ($43.12) | Avg Volume(3M) | 1.19M | Price | $73.25 |
| IPO | 1994/5/3 | Option/Short | Yes/Yes | Trades | 15068 | Volume | 1,364,377 | Change | 4.11% |
뉴스 로딩 중...